Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

712 studies match

clinicaltrialsPublishedShowing 51–100 of 712 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07291076	A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)	recruiting	Phase 1 / Phase 2	198	Bristol-Myers SquibbINDUSTRY	14	Sep 23, 2026	clinicaltrials
NCT07293351	A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)	recruiting	Phase 1 / Phase 2	474	Bristol-Myers SquibbINDUSTRY